Dosing Recommendation for PMDD
Start with 50 mg sertraline during the luteal phase (14 days prior to menses) rather than 25 mg, as this is the FDA-approved starting dose for PMDD and is supported by the strongest evidence. 1
Rationale Based on FDA Labeling
The FDA label for Zoloft explicitly states that the recommended starting dose for PMDD is 50 mg per day 1. This can be administered either:
- Intermittently (luteal phase only - starting 14 days before anticipated menses through onset of bleeding)
- Continuously (every day throughout the menstrual cycle)
For intermittent dosing specifically, the label indicates:
- Start at 50 mg/day during the luteal phase
- If inadequate response, increase to 100 mg/day in the next cycle (50 mg for first 3 days, then 100 mg for remaining days)
- Maximum dose: 100 mg/day for intermittent dosing 1
Supporting Research Evidence
While one study 2 examined 25 mg and 50 mg doses and found both effective for moderate-to-severe PMS, this study evaluated PMS, not PMDD - a critical distinction since PMDD represents more severe symptomatology requiring DSM-5 diagnostic criteria. The FDA approval trials for PMDD used 50-150 mg doses 1.
More recent high-quality evidence 3 from a 2015 multi-site RCT used 50-100 mg sertraline for symptom-onset dosing in PMDD patients, demonstrating significant improvement in depressive symptoms (IDS-C scores) and anger/irritability, with 67% response rates.
Clinical Algorithm
For luteal phase dosing:
- Start 50 mg daily beginning 14 days before expected menses
- Continue through onset of menstruation, then stop
- Assess response after 2 cycles
- If inadequate response: increase to 100 mg/day in next cycle (50 mg × 3 days, then 100 mg for remainder)
- Maximum luteal phase dose: 100 mg/day
Key advantage: No discontinuation symptoms occur with abrupt cessation after 2 weeks of treatment 4, making intermittent dosing well-tolerated.
Important Caveats
- Screen for bipolar disorder before initiating treatment 1
- Monitor closely for suicidality in first 1-2 weeks 1
- The 25 mg dose is appropriate for other anxiety disorders (panic disorder, PTSD, social anxiety) but not the FDA-recommended starting dose for PMDD 1
- Continuous dosing may be slightly more effective than luteal-phase-only dosing 5, but intermittent dosing reduces overall medication exposure and is FDA-approved
Bottom line: Use 50 mg, not 25 mg, as your starting dose for PMDD luteal phase treatment. This aligns with FDA guidance and the evidence base that established efficacy for this condition.